SynBiotic Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 1/6
SynBiotic has a total shareholder equity of €15.3M and total debt of €3.6M, which brings its debt-to-equity ratio to 23.7%. Its total assets and total liabilities are €34.9M and €19.6M respectively.
Anahtar bilgiler
23.7%
Borç/özkaynak oranı
€3.63m
Borç
| Faiz karşılama oranı | n/a |
| Nakit | €2.07m |
| Eşitlik | €15.33m |
| Toplam yükümlülükler | €19.59m |
| Toplam varlıklar | €34.92m |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: SBX's short term assets (€6.5M) do not cover its short term liabilities (€8.0M).
Uzun Vadeli Yükümlülükler: SBX's short term assets (€6.5M) do not cover its long term liabilities (€11.6M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: SBX's net debt to equity ratio (10.2%) is considered satisfactory.
Borcun Azaltılması: SBX's debt to equity ratio has increased from 0% to 23.7% over the past 5 years.
Bilanço
Nakit Pist Analizi
Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.
İstikrarlı Nakit Pisti: Insufficient data to determine if SBX has enough cash runway based on its current free cash flow.
Tahmini Nakit Akışı: Insufficient data to determine if SBX has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.